Moderna
MRNA
#1695
Rank
NZ$20.65 B
Marketcap
NZ$52.85
Share price
2.07%
Change (1 day)
-24.90%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$20.65 Billion

As of December 2025 Moderna has a market cap of NZ$20.65 Billion. This makes Moderna the world's 1695th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$20.65 B-24.59%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Dec 16th, 2025 the market cap of Moderna was reported to be:

NZ$20.22 Billion
by Nasdaq info icon info icon
NZ$20.23 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
NZ$0.97 B-95.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$429.11 B 1,978.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.44 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$89.73 B 334.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$448.80 B 2,073.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
NZ$15.51 B-24.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$877.78 B 4,150.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.15 B-75.02%๐Ÿ‡บ๐Ÿ‡ธ USA